Guardian Point Capital, LP Acumen Pharmaceuticals, Inc. Transaction History

Guardian Point Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.75 - $6.65 $637,500 - $1.13 Million	-170,000 Reduced 56.67%	130,000 $527,000
Q4 2022 Feb 14, 2023	SELL	$4.81 - $10.17 $480,999 - $1.02 Million	-100,000 Reduced 25.0%	300,000 $1.62 Million
Q3 2022 Nov 14, 2022	SELL	$4.44 - $10.48 $444,000 - $1.05 Million	-100,000 Reduced 20.0%	400,000 $4.01 Million
Q3 2021 Nov 15, 2021	BUY	$14.5 - $20.28 $7.25 Million - $10.1 Million	500,000 New	500,000 $7.43 Million

41.8M

57.7K

749K

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $72.5M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Guardian Point Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Point Capital, LP with notifications on news.